Nixodine is a nicotine-free alkaloid derived from nicotinic acid, a compound associated with the vitamin B3 family. While its molecular structure shares similarities with nicotine, Nixodine is a distinct compound — it is not nicotine, contains no tobacco, and is not derived from tobacco. Each KYTE pouch contains 6 mg of Nixodine and every batch is independently third-party lab tested.
Nixodine has been evaluated through toxicological testing, including assessments for mutagenic and carcinogenic potential, with testing indicating it is non-mutagenic and non-carcinogenic under the conditions evaluated.
It's the compound in every Kyte pouch. The section above has the full explanation.
Kyte is built without nicotine. Zero nicotine, ever.
Up to 45 minutes. Slow release, low-burn, no mess.
The first batch ships September 2026. Join the list for 40% off your first order.
40% off your first order. Your code arrives at launch. Ships September 2026.
You pay shipping at checkout in the US.
Nicotine and Nixodine compared
The nicotine way
Nicotine
Nicotine is a naturally occurring alkaloid derived from tobacco. It binds to nicotinic acetylcholine receptors (nAChRs) in the brain and throughout the body.
Known effects of nicotine
Can increase heart rate and blood pressure
Causes vasoconstriction (restricts blood flow)
Activates reward pathways
Can be habit-forming
Nicotine
Binds to nicotinic acetylcholine receptors (nAChRs)
The Kyte way
Nixodine
A different compound than nicotine. The card lists the contrast.
A different chemistry
Zero nicotine
Never tobacco-derived
6 mg Nixodine per pouch
Third-party tested every batch
Nixodine
Interacts with nicotinic acetylcholine receptors (nAChRs)
